Wednesday, February 10, 2010, 2:13PM AEST - The Australian Stockmarket closes in 1 hour and 52 minutes.
To create a watchlist or portfolio of shares, Register

TomoTherapy Incorporated (TOMO)

8:00AM AEST: 3.89 USD  Up 0.17 (4.57%)  
 MORE ON TOMO 
Quotes
HereSummary
Charts
Technical Analysis
News & Info
Company
Analyst Coverage
Ownership
Financials
 TomoTherapy Incorporated (NasdaqNM:TOMO) Delayed quote dataEdit
Last Trade:3.89 USD
Trade Time: 8:00AM AEST
Change:Up 0.17 (4.57%)
Prev Close:3.72
Open:3.83
Bid:3.33 x 2700
Ask:N/A
1y Target Est:4.25
Day's Range:3.74 - 3.93
52wk Range:1.99 - 4.67
Volume:149,024
Avg Vol (3m):169,722
Market Cap:208.91M
P/E (ttm):N/A
EPS (ttm):-0.82
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y 
 Add TOMO to Portfolio   Download Data

 HEADLINES 
TomoTherapy Enters Australian Market With Purchase by Royal Brisbane & Women's Hospital
Marketwire (Wed 1:05AM)
TOMOTHERAPY INC Financials
EDGAR Online Financials (Sun, Feb 7)
TomoTherapy to Announce Fourth-Quarter Results on Wednesday, February 17, 2010
Marketwire (Sat, Feb 6)
Law Offices of Howard G. Smith Announces Investigation on Behalf of Current and Former Employees of TomoTherapy Incorporated Who Invested in the Company's 401(k) Plan
Business Wire (Thu, Feb 4)
Addenbrooke's Hospital Begins Treating Patients on Second TomoTherapy(R) Cancer Treatment System
Marketwire (Wed, Feb 3)
Robbins Umeda LLP Announces Investigation of TomoTherapy Incorporated
Business Wire (Tue, Feb 2)
12 To 24 Month Payback For Hospital Investment In Radiation Oncology Equipment Creates Upside For The Stocks Of These Medical Equipment Suppliers
Wall Street Transcript (Tue, Jan 26)
TOMOTHERAPY INC Files SEC form 10-K/A, Annual Report
EDGAR Online (Fri, Jan 15)
TOMOTHERAPY INC Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Thu, Jan 14)
TomoTherapy to Present at Needham Growth Stock Conference
Marketwire (Tue, Jan 12)
More Headlines for TOMO...

 ANALYST 
EPS Est (next year) (Dec-09) :-0.82
EPS Est (in 2 years) (Dec-10) :-0.61
Avg Rec (current)*:3.0
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
TomoTherapy, Incorporated and its subsidiaries develop, manufacture, market, and sell the Hi Art system, a radiation therapy system for the treatment of various types of cancer.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News7 Indices